Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
MD

MD - MEDNAX Inc Stock Price, Fair Value and News

7.71USD+0.21 (+2.80%)Market Closed

Market Summary

MD
USD7.71+0.21
Market Closed
2.80%

MD Alerts

  • Big fall in earnings (Y/Y)

MD Stock Price

View Fullscreen

MD RSI Chart

MD Valuation

Market Cap

648.8M

Price/Earnings (Trailing)

-9.19

Price/Sales (Trailing)

0.32

EV/EBITDA

67.83

Price/Free Cashflow

5.74

MD Price/Sales (Trailing)

MD Profitability

EBT Margin

-3.06%

Return on Equity

-8.24%

Return on Assets

-3.26%

Free Cashflow Yield

17.42%

MD Fundamentals

MD Revenue

Revenue (TTM)

2.0B

Rev. Growth (Yr)

0.83%

Rev. Growth (Qtr)

-0.27%

MD Earnings

Earnings (TTM)

-70.6M

Earnings Growth (Yr)

-71.6%

Earnings Growth (Qtr)

103.25%

Breaking Down MD Revenue

Last 7 days

13.9%

Last 30 days

-0.4%

Last 90 days

-19.8%

Trailing 12 Months

-44.4%

How does MD drawdown profile look like?

MD Financial Health

Current Ratio

1.72

Debt/Equity

0.72

Debt/Cashflow

0.18

MD Investor Care

Shares Dilution (1Y)

0.46%

Diluted EPS (TTM)

0.61

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20242.0B000
20232.0B2.0B2.0B2.0B
20221.9B2.0B2.0B2.0B
20211.7B1.8B1.8B1.9B
20201.8B1.8B1.8B1.7B
20193.0B2.6B2.2B1.8B
20183.5B3.5B3.5B3.5B
20173.3B3.3B3.4B3.5B
20162.9B3.0B3.1B3.2B
20152.5B2.6B2.7B2.8B
20142.2B2.3B2.4B2.4B
20131.9B2.0B2.1B2.2B
20121.6B1.7B1.8B1.8B
20111.5B1.5B1.6B1.6B
20101.3B1.3B1.4B1.4B
200901.1B1.2B1.3B
20080001.1B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of MEDNAX Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jun 01, 2024
moore mary ann e
acquired
-
-
68,400
evp, general counsel & sec
Jun 01, 2024
richards c marc
acquired
-
-
95,760
evp, chief financial officer
Jun 01, 2024
pickert curtis
sold (taxes)
-5,489
7.31
-751
evp, chief operating officer
Jun 01, 2024
pickert curtis
acquired
-
-
68,400
evp, chief operating officer
Jun 01, 2024
wood lee
sold (taxes)
-5,943
7.31
-813
evp, natl & market operations
Jun 01, 2024
pickert curtis
gifted
-
-
-2,332
evp, chief operating officer
Jun 01, 2024
wood lee
acquired
-
-
51,300
evp, natl & market operations
Jun 01, 2024
swift james d
acquired
-
-
105,165
chief executive officer
May 09, 2024
sansone guy p
acquired
-
-
18,360
-
May 09, 2024
linynsky laura a
acquired
-
-
18,360
-

1–10 of 50

Which funds bought or sold MD recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jun 11, 2024
EverSource Wealth Advisors, LLC
added
12.9
598
8,382
-%
May 28, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
20,000
273,000
-%
May 28, 2024
Boston Partners
added
34.00
5,250,310
17,702,200
0.02%
May 20, 2024
Virtu Financial LLC
new
-
124,000
124,000
0.01%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-5.44
15,642
804,877
-%
May 16, 2024
COMERICA BANK
reduced
-9.6
-8,484
330,154
-%
May 16, 2024
JANE STREET GROUP, LLC
sold off
-100
-381,644
-
-%
May 16, 2024
Pineridge Advisors LLC
unchanged
-
78.00
1,073
-%
May 16, 2024
Tidal Investments LLC
new
-
441,561
441,561
0.01%
May 15, 2024
GOLDMAN SACHS GROUP INC
reduced
-29.84
-662,027
2,058,250
-%

1–10 of 49

Are Funds Buying or Selling MD?

Are funds buying MD calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MD
No. of Funds

Unveiling MEDNAX Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Jun 10, 2024
earnest partners llc
4.6%
3,876,602
SC 13G/A
Feb 14, 2024
alliancebernstein l.p.
9.4%
7,887,018
SC 13G/A
Feb 13, 2024
vanguard group inc
12.37%
10,393,239
SC 13G/A
Feb 12, 2024
earnest partners llc
5.7%
4,818,090
SC 13G/A
Feb 09, 2024
dimensional fund advisors lp
5.2%
4,409,901
SC 13G
Jan 22, 2024
blackrock inc.
16.2%
13,600,467
SC 13G/A
May 10, 2023
alliancebernstein l.p.
10.0%
8,392,304
SC 13G/A
Feb 14, 2023
alliancebernstein l.p.
7.8%
6,468,122
SC 13G/A
Feb 14, 2023
earnest partners llc
7.9%
6,546,580
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A

Recent SEC filings of MEDNAX Inc

View All Filings
Date Filed Form Type Document
Jun 17, 2024
8-K
Current Report
Jun 10, 2024
SC 13G/A
Major Ownership Report
Jun 04, 2024
4
Insider Trading
Jun 04, 2024
4
Insider Trading
Jun 04, 2024
4
Insider Trading
Jun 04, 2024
4
Insider Trading
Jun 04, 2024
4
Insider Trading
May 30, 2024
8-K
Current Report
May 13, 2024
4
Insider Trading
May 13, 2024
4
Insider Trading

Peers (Alternatives to MEDNAX Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
442.8B
379.5B
-8.31% 4.92%
28.82
1.17
12.96% -25.81%
95.1B
206.0B
-1.15% 24.54%
24.68
0.46
12.55% -43.95%
89.2B
66.7B
5.51% 17.43%
16.31
1.34
9.59% -4.59%
76.6B
360.9B
5.77% -9.91%
10.45
0.21
9.07% 78.83%
35.4B
155.5B
-14.95% 1.11%
12.95
0.23
6.34% 84.42%
12.8B
14.7B
7.24% 28.22%
15.68
0.87
7.99% 19.23%
12.5B
12.3B
1.71% 45.68%
15.29
1.01
5.77% 58.74%
MID-CAP
8.1B
2.3B
-5.85% -2.60%
28.41
3.51
5.96% 18.29%
6.3B
3.0B
2.92% -6.64%
-560.72
2.12
10.92% -104.06%
2.3B
1.5B
2.33% 34.16%
37.47
1.61
19.34% 40.15%
2.0B
3.5B
-10.48% -51.41%
13.87
0.57
-27.67% -62.40%
SMALL-CAP
2.0B
1.1B
7.81% 29.94%
29.74
1.8
11.45% 30.74%
1.3B
3.0B
-4.34% 62.81%
-7.33
0.42
4.98% 4.88%
59.8M
-
9.66% -15.93%
-3.96
-
- -1.05%
20.3M
21.6M
-6.43% 24.03%
39.87
0.94
9.04% -57.88%

MEDNAX Inc News

Latest updates
Yahoo New Zealand News17 Jun 202408:48 am
Yahoo Singapore News31 May 202402:03 am

MEDNAX Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-0.3%495496507501491514490486482499493473447417461415441459455439427
Operating Expenses-21.2%479608466452461478443436443431434423421384440381430418406396387
  S&GA Expenses13.4%60.0053.0057.0058.0059.0051.0058.0061.0061.0059.0067.0071.0067.0055.0066.0060.0067.0059.0063.0063.0059.00
EBITDA Margin-38.0%0.01*0.01*0.10*0.10*0.10*0.08*0.10*0.10*0.10*0.12*0.11*0.10*---------
Interest Expenses5.1%11.0010.0010.0011.0010.0010.0010.008.0012.0017.0018.0017.0018.0027.0027.0028.0028.0028.0030.0031.0030.00
Income Taxes126.0%4.00-14.569.0011.007.004.0010.0012.00-7.4013.0012.007.00-4.956.007.003.001.004.007.007.00-1.51
Earnings Before Taxes105.6%8.00-13831.0039.0021.0028.0039.0043.00-28.3554.0043.0038.000.0010.004.0010.00-17.4114.0020.0013.0011.00
EBT Margin-26.4%-0.03*-0.02*0.06*0.06*0.07*0.04*0.05*0.06*0.05*0.07*0.05*0.03*---------
Net Income103.2%4.00-12421.0028.0014.0030.0031.0027.00-21.1948.0031.0035.0018.00-64.30-41.04-672-18.719.00-1,255-8.24-242
Net Income Margin-16.6%-0.04*-0.03*0.05*0.05*0.05*0.03*0.04*0.04*0.05*0.07*0.01*-0.03*---------
Free Cashflow-280.8%-12569.0080.0089.00-10099.0083.0082.00-97.4844.0061.0054.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-2.3%2,1682,2202,3262,3062,3202,3482,3322,3702,3412,7232,6462,5552,4843,3483,4253,3874,3204,1464,2915,6395,706
  Current Assets-11.8%4274834213984094284244594408417887526651,5491,6516889417329659861,057
    Cash Equivalents-89.1%8.0073.0021.006.006.0010.009.0014.007.003873583382701,12429513231210825.0036.0046.00
  Net PPE-1.7%74.0076.0075.0073.0073.0073.0072.0072.0072.0070.0073.0068.0081.0076.0079.0098.0010073.0094.0093.0089.00
  Goodwill0.7%1,3931,3841,5321,5321,5321,5301,5321,5321,5291,5051,4971,4871,4821,4781,4812,1652,7101,4802,6354,0704,066
Liabilities-4.3%1,3121,3711,3581,3631,4101,4561,4731,5241,4641,8261,8001,7461,7172,6002,6202,5612,8322,6472,8112,9142,926
  Current Liabilities-36.4%247389350320284427352329270427398351327444488384346542501441415
  Long Term Debt-100.0%-618622625-632---------------
Shareholder's Equity0.8%8568499689429108928598458778978468097677488058271,4871,4991,4792,7252,780
  Retained Earnings2.7%-145-149-25.18-46.57-74.86-89.06-118-149-176-155-202-233-268-286-222-1794915105011,7571,801
  Additional Paid-In Capital0.3%1,0031,0009969929879849819971,0541,0501,0451,0391,0321,0291,0241,005995988978967978
Shares Outstanding0.0%84.0084.0084.0084.0082.0083.0082.0085.0085.0085.0085.0085.00---------
Minority Interest----------0.000.000.000.000.000.00------
Float----1,177---1,243---1,895---1,252---2,051-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-280.8%-125,22669,25079,93889,054-100,91798,68683,33082,407-97,48244,23661,10253,587-82,188-11,866169,935188,435-141,884135,297159,199120,032-56,817
  Share Based Compensation1.4%3,0673,0243,1643,1263,0093,2364,1204,3364,4354,0215,4955,7353,7172,92222,9465,7317,4435,8986,6599,86410,989
Cashflow From Investing-30.7%-16,238-12,424-14,004-10,398-11,350-11,241-6,088-13,352-26,273-15,584-41,21414,089-10,364840,611-3,441-1,439-20,220156,977-26,888-18,943-8,691
Cashflow From Financing1705.3%76,204-4,747-50,604-78,931108,567-86,289-82,662-62,146-256,457825-131851-761,661586-4,133-366,650366,039-209,499-143,150-107,08566,664
  Buy Backs-887-13311.007751,47021,47764,3981,166-2,4742511,994-2.005,4525012,54235641565,52778,982
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

MD Income Statement

2024-03-31
Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Net revenue$ 495,101$ 491,008
Operating expenses:  
Practice salaries and benefits369,138362,235
Practice supplies and other operating expenses31,08530,720
General and administrative expenses60,19859,059
Depreciation and amortization10,3088,953
Transformational and restructuring related expenses8,4800
Total operating expenses479,209460,967
Income from operations15,89230,041
Investment and other income2,013634
Interest expense(10,599)(10,390)
Equity in earnings of unconsolidated affiliate518427
Total non-operating expenses(8,068)(9,329)
Income before income taxes7,82420,712
Income tax provision(3,789)(6,506)
Net Income4,03514,206
Unrealized holding gain on investments, net of tax of $20 and $22760604
Total comprehensive income$ 4,095$ 14,810
Net income:  
Basic$ 0.05$ 0.17
Diluted$ 0.05$ 0.17
Weighted average common shares:  
Basic82,86381,894
Diluted83,27582,318

MD Balance Sheet

2024-03-31
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 7,998$ 73,258
Short-term investments107,473104,485
Accounts receivable, net283,749272,313
Prepaid expenses12,53213,525
Income taxes receivable5,1937,565
Other current assets9,57812,308
Total current assets426,523483,454
Property and equipment, net74,34075,639
Goodwill1,393,2491,384,166
Intangible assets, net18,75921,240
Operating and finance lease right-of-use assets70,27870,294
Deferred income tax assets101,942102,852
Other assets83,07482,165
Total assets2,168,1652,219,810
Current liabilities:  
Accounts payable and accrued expenses207,035350,798
Current portion of debt and finance lease liabilities, net16,40914,913
Current portion of operating lease liabilities21,03421,076
Income taxes payable2,8042,159
Total current liabilities247,282388,946
Line of credit80,0000
Long-term debt and finance lease liabilities, net613,347618,421
Long-term operating lease liabilities47,87347,238
Long-term professional liabilities255,870251,284
Deferred income tax liabilities34,10534,308
Other liabilities33,49230,552
Total liabilities1,311,9691,370,749
Commitments and contingencies
Shareholders' equity:  
Preferred stock; $.01 par value; 1,000 shares authorized; none issued00
Common stock; $.01 par value; 200,000 shares authorized; 84,008,436 and 84,018,023 shares issued and outstanding, respectively840840
Additional paid-in capital1,002,946999,906
Accumulated other comprehensive loss(2,154)(2,214)
Retained deficit(145,436)(149,471)
Total shareholders' equity856,196849,061
Total liabilities and shareholders' equity$ 2,168,165$ 2,219,810
MD
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
 CEO
 WEBSITEpediatrix.com
 INDUSTRYHealthcare Plans
 EMPLOYEES5250

MEDNAX Inc Frequently Asked Questions


What is the ticker symbol for MEDNAX Inc? What does MD stand for in stocks?

MD is the stock ticker symbol of MEDNAX Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of MEDNAX Inc (MD)?

As of Tue Jun 18 2024, market cap of MEDNAX Inc is 648.78 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MD stock?

You can check MD's fair value in chart for subscribers.

What is the fair value of MD stock?

You can check MD's fair value in chart for subscribers. The fair value of MEDNAX Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of MEDNAX Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MD so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is MEDNAX Inc a good stock to buy?

The fair value guage provides a quick view whether MD is over valued or under valued. Whether MEDNAX Inc is cheap or expensive depends on the assumptions which impact MEDNAX Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MD.

What is MEDNAX Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Jun 18 2024, MD's PE ratio (Price to Earnings) is -9.19 and Price to Sales (PS) ratio is 0.32. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MD PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on MEDNAX Inc's stock?

In the past 10 years, MEDNAX Inc has provided -0.184 (multiply by 100 for percentage) rate of return.